Detection of Chlamydia pneumoniae (Chlamydophila pneumoniae) DNA in atherosclerotic plaques and its molecular analysis in northern Greece by Chatzidimitriou, Dimitris et al.
 Chlamydia Pneumoniae in Atherosclerotic Plaques and its Molecular Analysis 45
INTRODUCTION
Chlamydia pneumoniae (Chlamydophila pneumoniae) 
is a Gram negative intracellular bacterium responsible 
for acute upper and lower respiratory tract infections1 
and for many years scientific interest has been focused 
on its possible association with chronic diseases such 
as atherosclerosis2. The first association between C. 
pneumoniae and coronary artery disease (CAD) was 
based on serologic studies in Finland in which high ti-
ters of IgG and IgA antibodies to C. pneumoniae were 
found significantly more often in men with myocar-
dial infarction and chronic CAD than in age-matched 
randomly selected controls3. Since then a number 
of observational studies followed demonstrating the 
presence of C. pneumoniae by multiple methods such 
as electron microscopy, immunocytochemistry and 
polymerase chain reaction (PCR) not only in coronary 
but in various atherosclerotic arteries. However, there 
is as yet no conclusive evidence about the role of C. 
pneumoniae in atherosclerosis.
The aim of this study was the detection of Chla-
mydia pneumoniae DNA in atherosclerotic plaques by 
nested «Touchdown» PCR targeting the OmpA gene. 
Nested PCR was used because it is considered more 
sensitive than single-step PCR, and «Touchdown» 
PCR increases specificity by allowing the initial prim-
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er-template hybridization events to occur at annealing 
temperatures that are greater than the optimum anneal-
ing temperature. In order to investigate whether there 
is a relation between a specific type of C. pneumoniae 
and atherosclerosis, genotyping was performed. 
PATIeNTS
The study group consisted of 122 patients (mean age 
68.4, range 50-89 years old, 95 males and 25 females) 
with severe atherosclerosis and therefore underwent 
elective surgery for atherosclerotic plaque removal 
from May 2004 to April 2006. An equal number of 
atherosclerotic plaques (carotid artery, n = 50; femoral 
artery, n = 40; abdominal aorta, n = 32) were immedi-
ately transferred to the laboratory (15-20 min), where 
they were homogenized with the use of mortar and 
liquid nitrogen. The homogenized samples were given 
a code number, divided into four aliquots and stored at 
-70°C for PCR studies.
MeThODS
DNA extraction
DNA extraction from the atherosclerotic plaque was 
performed using the DNA mini kit of Qiagen (Greece, 
BioAnalytica S.A.) according to the manufacturer’s 
recommendations. Briefly the method uses a QIAamp 
spin column to which DNA binds in the presence of 
buffer AL and ethanol. Two wash steps, in which AW1 
buffer and AW2 buffer succeed each other, are per-
formed to remove contaminants. AE buffer is finally 
used for elution of the DNA from the spin column.
Detection of C. pneumoniae ompA gene
The presence of C. pneumoniae in the 122 atheroscle-
rotic plaques was detected by a nested «Touchdown» 
PCR method. The major outer protein genes (ompA) 
of C. pneumoniae were chosen as the target for ampli-
fication as previously described by Tong and Sillis [4]. 
The external primers, CP1: 5΄TTA CAA GCC TTG 
CCT GTA GG3΄ and CP2: 5΄GCG ATC CCA AAT 
GTT TAA GCG 3΄ amplified a 333 base pair product, 
and the internal primers CP6: 5΄TTA TTA ATT GAT 
GGT ACA ATA 3΄ and CPD: 5΄ATC TAC GGC AGT 
AGT ATA GTT 3΄ amplified a 207 base pair product. 
The first stage of PCR was performed in a 100μl final 
volume containing: 10 μl of the extracted DNA, PCR 
buffer 10X (200mM Tris-HCl, pH 8.4 and 50mM 
KCl), 0.4 μM each of outer primers, 1.5 mM MgCl2, 
200 μΜ each deoxyribonucleotide (dATP, dTTP, 
dCTP and dGTP) and 2.5U Taq polymerase (Invitro-
gen, UK). Touchdown PCR was performed in which 
the annealing temperature was lowered 1ο C every two 
cycles from 64ο C until touching down to 55ο C, at 
which temperature 30 more cycles were programmed. 
The denaturation and extension temperature were con-
stant at 94ο and 72ο C, respectively. The holding time 
of each temperature was 1 minute. In order to check 
the quality of the extraction process and the possible 
presence of PCR inhibitors, b-Globine specific prim-
ers were used in each reaction, KM29: 5΄GGT TGG 
CCA ATC TAC TCC CAG G 3΄ and RS42: 5΄GCT 
CAC TCA GTG TGG CAA AG 3΄, which amplified a 
536 base pair product (Figure 1). 
The PCR products amplified by the external prim-
ers were diluted 10 times in DNase free water and 10μl 
of it was transferred to a PCR reaction mix for the 
second stage of amplification using the internal prim-
ers. The PCR reaction mix was the same as the first 
one, with two exceptions; 1 μM of each of the internal 
primers was used and the ΜgCl2 concentration was in-
creased to 3 mM. This PCR second stage PCR consist-
ed of 30 cycles of 94ο, 50ο and 72οC each for 1 minute. 
Table 1. Detection of C. pneumoniae DNA in atherosclerotic plaques.
Sample origin No of samples tested PCR positive   No.                                    %
Carotid artery 50 6 12
Abdominal aorta 32 5 15.6
femoral 40 4 10
Total 122 15 12.3
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Both first and second stage products were analyzed 
in 2% gel electrophoresis. Every sample revealed a 
β - Globine 536 base pair in the first stage PCR and 
after second PCR the positive results revealed a 207 
base pair fragment (Figure 2). Positive and negative 
controls were included in every PCR run. 
Detection of ygeD-Urk gene
The positive samples for C. pneumoniae presence 
were further studied. It has been reported that C. pneu-
moniae strains differ in the plasticity zone between 
the ygeD and urk genes by the orientation of a 23 bp 
sequence. Therefore in this study a 568 bp fragment 
targeting this region was amplified using a nested 
PCR. The external primers were ygeD1: 5΄GTT AGG 
GTG GTT TTC CCA GC 3΄ and ygeD2: 5΄GAG ATA 
ACG ATT CTG AGG CC 3΄ and the internal, ygeD3: 
5΄ CCA GAA CCT CCT GTA ATT CC3΄ ygeD4: 
5΄GCT GTT CTA CAA GCA AAT CAC CC 3΄. The 
first stage PCR was performed in a final volume of 50 
μl containing: 5μl DNA, PCR buffer 10Χ (200 mM 
Tris-HCl, pΗ 8.4 and 50 mM ΚCl), 0.5 μΜ from each 
primer, 1.5 mM MgCl2, 200 μΜ of each deoxyribo-
nucleotide (dATP, dTTP, dCTP and dGTP) and 2.5 U 
Taq polymerase (Taq DNA polymerase, recombinant, 
Invitrogen, UK). PCR conditions consisted of an ini-
tial denaturation at 95οC for 5 min, followed by 40 
cycles of denaturation at 94οC, annealing at 56οC, and 
extension at 72οC, all for 1 min, and a final extension 
at 72οC for 10 min.
The second stage PCR was performed in a final 
volume of 50 μl containing 1 μl of the product from 
the first PCR, PCR buffer 10Χ (200 mM Tris-HCl, pΗ 
8.4 and 50 mM ΚCl), 0.5 μΜ from each primer, 1.5 
mM MgCl2, 200 μΜ each deoxyribonucleotide (dATP, 
dTTP, dCTP, and dGTP) and 2,5 U Taq polymerase 
(Taq DNA Polymerase, recombinant, Invitrogen, 
UK). The PCR conditions remained the same except 
from the annealing temperature that was modified to 
51οC. The samples revealed in electrophoresis a 371 
bp fragment.
All products were analyzed in 2% agarose gel elec-
trophoresis with ethidium bromide staining. 
Sequencing of PCR products and analysis
Both PCR products were purified using the commer-
cial kit Chargeswitch PCR cleanup kit (invitrogen, 
UK) according to the manufacturer’s instruction. 
Purified PCR products were sequenced (Lark Tech-
nologies, Congenics Ltd, Essex, UK) using the CP6: 
5΄TTA TTA ATT GAT GGT ACA ATA 3΄ and CPD: 
5΄ATC TAC GGC AGT AGT ATA GTT 3΄primers, 
and ygeD3: 5΄ CCA GAA CCT CCT GTA ATT CC3΄ 
and ygeD4: 5΄GCT GTT CTA CAA GCA AAT CAC 
CC 3΄, for each amplified product.
Sequences were further analyzed using bioin-
L     64     65     66     67     68     69     70     71     (-)
Figure 1. Representative agarose gel electrophoresis of first 
stage PCR. L: Molecular size ladder (100bp), 64, 65, 66, 67, 
68, 69, 70, 71: samples of atherosclerotic plaques, (-): negative 
control. All show a 536 bp fragment for β-Globin.
L     (+)     (-)     27     16     37
Figure 2. Representative agarose gel electrophoresis of 
second stage PCR. L: Molecular size ladder (100bp),(+): 
positive control, (-): negative control, 27, 16, and 37: ath-
erosclerotic plaque samples. 
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formatic tools. In particular, related sequences were 
found using the BLAST tool trough the National 
Center for Biotechnology Information (NCBI, http://
www.ncbi.nlm.nih.gov/), while the multiple sequence 
alignments were generated with ClustalW from the 
European Bioinformatics Institute. Furthermore, the 
phylogenetic and molecular evolutionary analysis was 
conducted using MEGA3.1.
Statistical analysis
Statistical analysis for discrete variables was made by 
the x2 test. After controlling for normal distribution, 
continuous variables were analyzed by the Mann-
Whitney test. P < 0.05 was considered significant.
ReSUlTS
Overall, 15 of 122 (12.3%) atherosclerotic speci-
mens from patients were positive for C. pneumoniae 
by PCR (table 1). Detection rates of C. pneumoniae 
in arterectomy specimens of carotid, abdominal, and 
femoral arteries were 12%, 15.6%, 10 % respectively. 
The detection rates comparing the various atheroscle-
rotic tissues were not significantly different (p = 0.64, 
p = 0.76, p = 0.47). 
The ompA region amplified (207 bp) was sequenced 
of the 15 positive samples and showed that they were 
identical and revealed 100% homology to the C. 
pneumoniae J138 strain (NP_300751) and less with 
other species of chlamydophila genus C. psittaci FPN 
(Q00087), C. pecorum LW613 (CAD29328) and C. 
trachomatis L2 (P06597). The alignment of the amino 
acid sequence of the detected ompA with other known 
ompA sequences of the genus is presented in Figure 
3. The amino acid sequence is relatively conserved 
Figure 3. Alignment of CpnThessaloniki ompA with 
other ompA. The deduced amino-acid sequence for Cp-
nThessaloniki ompA was compared to C. pneumoniae 
J138 (NP_300751), C. psittaci FPN (Q00087), C. pecorum 
LW613 (CAD29328) and C. trachomatis L2 (P06597). 
The black and grey shading indicates identical and similar 
amino-acids in properties, respectively. The four VDs are 
boxed, while the conserved cysteines are indicated with an 
asterisk.
Figure 4. Phylogenetic relatedness of CpnThessaloniki 
ompA to other known ompA. Deduced amino acid se-
quences were analyzed by Neighbor-Joining (NJ) using 
MEGA 3.1. The cladogram was generated from an alignment 
of CpnThessaloniki with C. felis FP Cello (AAK00239), C. 
felis FEIS-M (AAO24108), C. caviae GPIC (AAK00263), 
C. psittaci NJ1 (AAK00247), C. psittaci WS/RT/E30 
(AAX09977), C. psittaci 6BC (CAA40300), C. pneumoni-
ae WBB (ABC86832), C. pneumoniae J138 (NP_300751), 
C. pneumoniae LKK-1 (AAT68197), C. pecorum LW613 
(CAD29328), C. pecorum L71 (AAK00261), C. trachoma-
tis serovar L2 strain L2/434/Bu (P06597), C. trachomatis 
serotype D 78BH2004 (ABE02281), C. trachomatis sero-
type H IS1075 (AAL61634) and C. trachomatis serotype H 
3430 (CAJ46707).
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between the species of chlamydophila, but there can 
be identified four distinct regions (variable domains, 
VDs) with lower conservations. The ompA domain 
isolated contains a highly conserved region, as well as 
the VD1 domain (Figure 3). Furthermore, three out of 
seven conserved cysteins responsible for the sulphid 
bond were identified in our sequence (Figure 3). The 
phylogenetic relatedness of the isolated amino acid 
sequence with other known chlamydophila ompAs is 
presented in Figure 4. The strain is grouped with other 
strains of C. pneumoniae like J138, WBB and LKK-1. 
Four further groups were presented (Figure 4). 
As far as it concerns the intergenic spacer region 
between ygeD and urk genes (371 bp) used for the 
genotyping, 14 of our strains were identical and 100% 
homologous to J138, AR39 and TW-183 strains, while 
one sample (Carotid atherosclerotic plaque, 37) had 
the 23 bp invertible region and revealed 100% homol-
ogy with the CWL029 strain. The alignment of the 
amino acid sequences is shown in Figure 5. This find-
ing indicates that the strains isolated from the samples 
belong into two different types. The phylogenetic rela-
tionship of the amino acid sequences isolated from dif-
ferent samples with known ygeD-urk regions supports 
this finding (Figure 6).
DISCUSSION 
The «infectious» hypothesis as a causal role of athero-
Figure 5. Alignment of the fragment ygeD-urk gene of 
CpnThessaloniki I and II with various C. pneumoniae 
isolates. The deduced amino-acid sequence for CpnThes-
saloniki I and II ygeD-urk region was compared to J138 
(BA000008), TW-183 (AE017159), AR39 (AE002161), 
CWL029 (AE001363) WBB (DQ463439) and CpnIII 
(AY427827). The black and grey shading indicates identi-
cal and similar amino-acids in properties, respectively. The 
amino-acid residues in the blue box are a 23 bp inverted se-
quence, while those in orange boxes are the 15 bp inverted 
repeats. The amino-acids indicated with an asterisk are di-
versified in WBB and CpnIII.
Figure 6. Phylogenetic relatedness of the fragment 
ygeD-urk gene of CpnThessaloniki I and II with vari-
ous C. pneumoniae isolates. Deduced amino acid sequenc-
es were analyzed by Neighbor-Joining (NJ) using MEGA 
3.1. The cladogram was generated from an alignment of 
CpnThessaloniki I and II with J138 (BA000008), TW-183 
(AE017159), AR39 (AE002161), CWL029 (AE001363) 
WBB (DQ463439) and CpnIII (AY427827).
50 Aristotle University Medical Journal, Vol. 36, Issue 1, February 2009
sclerosis is surprisingly old since infectious agents 
have been proposed to participate in the disease since 
the late 1800s and early 1900s5. In 1908 Sir William 
Osler suggested that “acute infections” including 
scarlet fever, measles, diphtheria, smallpox and in-
fluenza might be responsible for atherosclerosis6. In a 
1911 paper, Frothingham7 reported that «acute infec-
tious diseases may cause some pretty general lesion 
throughout the arterial system by the infecting organ-
isms. The exact nature of these lesions in human cases 
and their final result, have not been so well worked 
out». A century later, scientists have not yet come to 
an agreement about this association. Meanwhile, Fab-
ricant et al8 were the first researchers to experimen-
tally induce atherosclerosis in chickens by inoculation 
with a chicken herpesvirus that induces fibrolympho-
matosis. The induction of atherosclerotic changes 
was prevented by vaccination. Since then, a number 
of microorganisms have been implicated in athero-
sclerosis including Cytomegalovirus (CMV), Herpes 
simple virus (HSV), H. pylori and C. pneumoniae, all 
possessing an important similarity as they are all obli-
gate intracellular pathogens capable of maintaining a 
chronic persistent state in the host5,9-11.
The present study works on the detection of C. 
pneumoniae DNA in atherosclerotic plaques. Since 
Saikku et al.3 demonstrated serological evidence of an 
association of C. pneumoniae with chronic coronary 
heart disease and acute myocardial infection, the re-
search on the infection hypothesis and particularly by 
the specific microorganism has significantly boosted. 
Many research groups using various techniques have 
tried to link C. pneumoniae to chronic diseases such 
as atherosclerosis. 
However, recently, serious doubts have been raised 
about the role of C. pneumoniae in atherosclerosis not 
only from the experimental studies12,13 but primarily 
due to the negative results of large antibiotic trials 
investigating the efficacy of antibiotic treatment for 
the secondary prevention of cardiovascular events14. 
These results have suggested that the infection hy-
pothesis is possibly wrong and that the microorganism 
is just an innocent bystander in the vascular wall.
In our study we demonstrated the presence of C. 
pneumoniae in 12.3%, (15/122) atherosclerotic sam-
ples analyzed by PCR. This low detection rate of C. 
pneumoniae DNA in the atherosclerotic samples is 
probably due to the presence of low density of the 
microorganism in the atherosclerotic lesion or to the 
high specificity PCR. In other studies using different 
PCR methods, the detection rate of C. pneumoniae 
DNA varies between 0-75%. For example in 1993, 
Kuo et al detected C. pneumoniae DNA by PCR in 
43.3%, 13/30, of coronary atheromatic arteries in 
autopsy cases from South Africa15. In 1996, Blasi et 
al detected the bacterial DNA in 51%, 26/51 of the 
atheromatic plaques tested16, while Mass et al. also 
detected it in atherosclerotic coronary arteries in a ra-
tio of 30%, 21/7017. In 1999, Jantos et al detected the 
DNA of C. pneumoniae in 8% of patients with coro-
nary artery disease18 , while Nadrchal et al. found it in 
28 % of the atheromatic carotid plaques19. Moreover, 
Farsak et al, in 2000, detected the microorganism in a 
ratio of 26 %20, while Cochrane et al., in 2002 in Aus-
tralia, detected it in 2 out of 28 atheromatic plaques 
(7.14 %)21. Undoubtedly, in 2003, Zamorano et al. us-
ing the same PCR method found C. pneumoniae DNA 
in 75% of patients with unstable angina undergoing 
bypass surgery22.
Although, few studies haven’t succeeded to detect 
C. pneumoniae DNA in any atherosclerotic plaque and 
reject the role of the microorganism in atherosclerosis, 
the presence of C. pneumoniae DNA in our patients, 
as in previous studies mentioned before, preserves 
the interest of the participation of C. pneumoniae in 
atherosclerosis13,23.
According to the sequence analysis of the ompA re-
gion amplified, our strains were identical and revealed 
100% homology with the respiratory strain J138. 
A recent study comparing the strains CWL029 and 
AR39 reported a differentiation in the plasticity zone 
between the ygeD and urk genes by the orientation 
of a 23 bp sequence24. This region has been used in 
the sequencing of C. pneumoniae by other research-
ers as well, although, this kind of studies are quite re-
cent and rare25,26. The 23 bp invertible region in the C. 
pneumoniae plasticity zone is in the forward orienta-
tion in 3 respiratory reference strains and one ocular 
(J138, AR39, IOL207, TW183); and in the reverse 
orientation in one of the strains, (CWL029). Further 
molecular analysis of our strains based on the orienta-
tion difference of the 23 bp region between the ygeD-
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urk genes revealed that 14/15 strains were identical to 
each other and to 3 respiratory and one ocular strain 
studied, designated CpnThessaloniki I. One strain, 
designated CpnThessaloniki II had the reverse orien-
tation of the 23 bp region and was 100% identical to 
the respiratory reference strain CWL029.
Concluding, C. pneumoniae DNA was detected in 
15 out of 122 (12.3%) atherosclerotic specimens from 
patients undergoing elective surgery. This result pre-
serves the hypothesis that the microorganism could be 
a possible etiological co-factor in the pathogenesis of 
atherosclerosis. 
The strains detected in the samples belong to two 
different types designated as CpnThessaloniki I and 
II. CpnThessaloniki I was the prevalent and only one 
strain had the reverse orientation of the 23bp region in 
northern Greece. All our strains were 100% homolo-
gous to other respiratory and ocular strains. 
ΠΕΡΙΛΗΨΗ: Το Χλαμύδιο της πνευμονίας είναι αίτιο λοιμώξεων του αναπνευστικού αλλά έχει συσχετισθεί και με την 
παθογένεια χρόνιων νοσημάτων όπως η αθηροσκλήρωση. 
Σκοπός της παρούσας μελέτης είναι η ανίχνευση του DNA του Χλ. της πνευμονίας σε αθηρωματικές πλάκες από διάφορα 
αγγεία με τη χρήση PCR υψηλής ειδικότητας και ευαισθησίας. Για την περαιτέρω διερεύνηση της σχέσης κάποιου τύπου 
του μικροοργανισμού με την αθηρωμάτωση, έγινε γενετική τυποποίηση. 
Μέθοδοι. Εξετάστηκαν 122 αθηρωματικές πλάκες από ισάριθμους ασθενείς. (μέσος όρος ηλικίας 68,4, ηλικιακό εύρος 50-89 
έτη, 95 άρρενες και 25 θήλεις) με προχωρημένου βαθμού αθηροσκλήρωση. Για την ανίχνευση του DNA του μικροοργανισμού 
εφαρμόστηκε η nested Touchdown PCR και για την περαιτέρω ανάλυση, μια nested PCR με εκκινητές που στοχεύουν στην 
ygeD-urk περιοχή. Έγινε αλληλούχηση και ανάλυση των προϊόντων των PCR. 
Αποτελέσματα: Στο 12,3% των δειγμάτων ανιχνεύθηκε DNA του μικροοργανισμού. Η αναλογία ανίχνευσης ανάλογα με το 
αγγείο προέλευσης της αθηρωματικής πλάκας, καρωτίδες, κοιλιακή αορτή και μηριαίες αρτηρίες ήταν 12%, 15,6% και 10% 
αντίστοιχα. (p = NS). 14 από τα στελέχη μας είχαν 100% ομολογία με τα στελέχη J138, AR39 και TW183 και ένα στέλεχος 
είχε στην yged-urk περιοχή, ένα τμήμα 23 ζβ με ανάστροφο προσανατολισμό και εμφάνισε 100% ομολογία με το στέλεχος 
CWL029. 
Συμπεράσματα: Στα15/122 (12,3%) δείγματα ανιχνεύθηκε γενετικό υλικό του μικροοργανισμού. Τα ανιχνευθέντα στελέχη 
κατηγοριοποιήθηκαν σε δύο γονότυπους, Ι και ΙΙ. Ο γονότυπος Ι ήταν ο επικρατέστερος και ένα μόνο στέλεχος είχε το τμήμα 
των 23ζβ ανάστροφο. 
Λέξεις Κλειδιά: Χλαμύδιο της πνευμονίας, Αθηροσκλήρωση, PCR, Μοριακή ανάλυση.
Ανίχνευση DNA του Χλαμυδίου της πνευμονίας (Χλαμυδόφιλα της πνευμονίας)  
σε αθηρωματικές πλάκες και η μοριακή του ανάλυση στη βόρεια Ελλλάδα
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